2 min read
Prevagen Supplement Marketing Under Scrutiny: Jury Finds Quincy Bioscience Liable for False Advertising
N
Nishica Srivastava
December 26, 2024

Table of Contents
Federal Trade Commission Et Al V. Quincy Bioscience Holding Company, Inc. Et Al
Case Background
Cause
Continue Reading This Article
Subscribe to access this article and our entire library of legal content.
Unlimited access to all articles
Expert legal analysis and insights
Downloadable resources and templates
Categories
Tags
Consumer Protection
Deceptive Practices
False Advertising Lawsuit
Injunction
Misleading
Prevagen
About the Author
NS
Nishica Srivastava
Writer